Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
REVELATION BIOSCIENCES, INC. issued 17,089,998 pre-split (4,272,500 post-split) new common stock warrants of warrant to two holders for aggregate gross proceeds of approximately $7.3 million from the exercise of Existing Warrants.
- Security
- warrant
- Shares
- 17,089,998 pre-split (4,272,500 post-split) new common stock warrants
- Purchaser
- two holders
- Consideration
- aggregate gross proceeds of approximately $7.3 million from the exercise of Existing Warrants
Exact text from the filing
new common stock warrants (the “Class J Common Stock Warrants”) as described below. The aggregate gross proceeds from the exercise of the Existing Warrants is approximately $7.3 million, before deducting financial advisory fees. The issuance of the Class J Common Stock Warrants was structured as an at-market transaction under Nasdaq rules. The Company intends to
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
REVELATION BIOSCIENCES, INC. entered into Inducement Letters with two holders valued at approximately $7.3 million (effective 2026-01-23).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- two holders
- Value
- approximately $7.3 million
- Effective
- 2026-01-23
Exact text from the filing
On January 23, 2026, Revelation Biosciences, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with two holders
View on SEC.gov